Alnylam Pharmaceuticals | ALNY - الدائنين التجاريين





الدائنين التجاريين تغيير تاريخ
Acadia Pharmaceuticals USD 44.57M 32.32M 2026-06
Agios Pharmaceuticals USD 16.34M 2.6M 2026-06
Alnylam Pharmaceuticals USD 108.02M 18.61M 2026-06
Amgen USD 2.86B 16.65B 2026-06
Arrowhead Research USD 27.78M 2.97M 2026-06
BioCryst Pharmaceuticals USD 11.46M 501K 2026-06
BioMarin Pharmaceutical USD 913.67M 120.52M 2026-06
Incyte USD 1.39B 1.16B 2026-06
Ionis Pharmaceuticals USD 47.7M 21.67M 2026-06
Moderna USD 167M 6M 2026-06
Neurocrine Biosciences USD 691.3M 145.8M 2026-03
Novartis USD 4.32B 134M 2026-03
PTC Therapeutics USD 40.45M 14.96M 2026-06
Regeneron Pharmaceuticals USD 1.16B 132.2M 2026-06
Sangamo BioSciences USD 10.74M 7.46M 2025-06
Sanofi EUR 22.71B 219M 2026-03
Sarepta Therapeutics USD 50.98M 19.39M 2026-06
Takeda JPY 446.78B 44.56B 2026-06
Tectonic Therapeutic USD 2.55M 1.46M 2026-03
Ultragenyx Pharmaceutical USD 39M 3M 2026-06
Vertex Pharmaceuticals USD 3.61B 135M 2026-06
Xencor USD 12.65M 4.73M 2026-06